We serve Chemical Name:Etocrilene CAS:5232-99-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Etocrilene
CAS.NO:5232-99-5
Synonyms:Ethyl α-cyan-β,β-diphenylacrylate;Ethyl α-cyano-β-phenylcinnamate;Etocrilene;MFCD00027364;Ethyl 2-cyano-3,3-diphenylacrylate;Ethyl α-cyano-β,β-diphenylacrylate;2-Propenoic acid, 2-cyano-3,3-diphenyl-, ethyl ester;EINECS 226-029-0;2-Cyano-3,3-diphenyl-2-propenoic acid ethyl ester;ethyl 2-cyano-3,3-diphenylprop-2-enoate;Acrylic acid, 2-cyano-3,3-diphenyl-, ethyl ester (8CI);2-Cyano-3,3-diphenylacrylic acid ethyl ester
Molecular Formula:C18H15NO2
Molecular Weight:277.317
HS Code:2926909090
Physical and Chemical Properties:
Melting point:97-99 °C(lit.)
Boiling point:407.6±33.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.578
PSA:50.09000
Exact Mass:277.110291
LogP:4.52
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3077 9/PG 3
Packing Group:
Contact us for information like Ethyl α-cyan-β,β-diphenylacrylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Cyano-3,3-diphenylacrylic acid ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Cyano-3,3-diphenyl-2-propenoic acid ethyl ester Use and application,Acrylic acid, 2-cyano-3,3-diphenyl-, ethyl ester (8CI) technical grade,usp/ep/jp grade.
Related News: Standard therapy consisted of oral corticosteroids (OCS), antimalarials and immunosuppressants (methotrexate, azathioprine or mycophenolate mofetil, known as MMF). (4,4′,4′,4”-Tetrasulfophthalocyaninato)cobalt manufacturers Moreover, the improved stereoselectivity further enhances product purity by ensuring that only one stereoisomer reacts where a mixture of stereoisomers is present. 3-amino-6-(4-fluorophenyl)pyridine-2-carboxamide suppliers In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April. 1-(2-Chloroethoxy)-3-nitrobenzene vendor & factory.
